Therapeutic cancer vaccines are developed to treat existing cancer by boosting the immune system's response to cancer cells. These vaccines often contain cancer-specific antigens, which are substances that the immune system can recognize as foreign. Examples include the Provenge (sipuleucel-T) vaccine for prostate cancer, which uses a patient's own immune cells to stimulate an immune response against prostate cancer cells.
